Article Type
Changed
Fri, 01/18/2019 - 08:39
Display Headline
Transdermal progesterone ineffective for menopausal symptoms
PRACTICE RECOMMENDATIONS

Transdermal progesterone cream, at the dose used in this study, did not improve menopausal symptoms compared with placebo. The study, however, might not have been large enough to detect a difference if one really exists.

In light of recent safety concerns over the use of other types of hormone replacement therapy, treatment of menopausal symptoms with transdermal progesterone should not be used unless better information supporting its benefit becomes available.

 
Article PDF
Author and Disclosure Information

Practice Recommendations from Key Studies

Wren BG, Champion SM, Willetts K, Manga RZ, Eden JA. Transdermal progesterone and its effect on vasomotor symptoms, blood lipid levels, bone metabolic markers, moods, and quality of life for postmenopausal women. Menopause 2003; 10:13–18.

Deborah Sturpe, PharmD, BCPS
Department of Pharmacy Practice and Science University of Maryland School of Pharmacy, Baltimore

[email protected]

Issue
The Journal of Family Practice - 52(5)
Publications
Topics
Page Number
349-364
Sections
Author and Disclosure Information

Practice Recommendations from Key Studies

Wren BG, Champion SM, Willetts K, Manga RZ, Eden JA. Transdermal progesterone and its effect on vasomotor symptoms, blood lipid levels, bone metabolic markers, moods, and quality of life for postmenopausal women. Menopause 2003; 10:13–18.

Deborah Sturpe, PharmD, BCPS
Department of Pharmacy Practice and Science University of Maryland School of Pharmacy, Baltimore

[email protected]

Author and Disclosure Information

Practice Recommendations from Key Studies

Wren BG, Champion SM, Willetts K, Manga RZ, Eden JA. Transdermal progesterone and its effect on vasomotor symptoms, blood lipid levels, bone metabolic markers, moods, and quality of life for postmenopausal women. Menopause 2003; 10:13–18.

Deborah Sturpe, PharmD, BCPS
Department of Pharmacy Practice and Science University of Maryland School of Pharmacy, Baltimore

[email protected]

Article PDF
Article PDF
PRACTICE RECOMMENDATIONS

Transdermal progesterone cream, at the dose used in this study, did not improve menopausal symptoms compared with placebo. The study, however, might not have been large enough to detect a difference if one really exists.

In light of recent safety concerns over the use of other types of hormone replacement therapy, treatment of menopausal symptoms with transdermal progesterone should not be used unless better information supporting its benefit becomes available.

 
PRACTICE RECOMMENDATIONS

Transdermal progesterone cream, at the dose used in this study, did not improve menopausal symptoms compared with placebo. The study, however, might not have been large enough to detect a difference if one really exists.

In light of recent safety concerns over the use of other types of hormone replacement therapy, treatment of menopausal symptoms with transdermal progesterone should not be used unless better information supporting its benefit becomes available.

 
Issue
The Journal of Family Practice - 52(5)
Issue
The Journal of Family Practice - 52(5)
Page Number
349-364
Page Number
349-364
Publications
Publications
Topics
Article Type
Display Headline
Transdermal progesterone ineffective for menopausal symptoms
Display Headline
Transdermal progesterone ineffective for menopausal symptoms
Sections
Disallow All Ads
Article PDF Media